EQ-5D
anxiety/depression
In the IMS III trial, the EQ-5D with 3 levels was used. The EQ-5D consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.Assessment of the EQ-5D dimension scores was performed at 90 days after inclusion by study investigators who were not directly involved with acute treatment of the patient and who were blinded to treatment assignment. Information was obtained from the patient, if possible, and a proxy. For this study, we used the EQ-5D dimension scores as indicated by the patient. If not available, we used the EQ-5D dimension scores as indicated by their proxy. For some patients, EQ-5D dimension scores for both an in-person and telephone assessment were available. In those cases, the scores from the in-person assessment were used.